MICHAEL SEDLACEK: Open Payments
NPI 1477546372 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,512 in 10 payments from 5 companies in 2025. Trend: 2023 $15 · 2024 $169 · 2025 $7,512
Consulting: $7,300Food & beverage: $115Travel & lodging: $97
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company | 5 | $7,422 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: CAPLYTA, Auvelity, VRAYLAR, FANAPT.
Industry payments across NE — which companies pay providers there.
